Salt Lake City-based Inherent Biosciences Inc., a health care diagnostic startup, is growing its presence in the Spokane area since first expanding here in 2024 through $1.25 million in grants from Health Sciences & Services Authority of Spokane County.

Amid ongoing political, social, and economic uncertainty and tumult, demand for ketamine infusion therapy at the Ketamine Clinic of Spokane LLC has remained steady as patients seek tools to manage depression, anxiety, and emotional overload, often compounded by collective stress.

The first phase of a $42 million modernization project at Providence Heart Institute is now underway.

As the cost of health insurance rises, employers looking to reduce costs while still providing generous health and wellness benefit packages for their employees should explore options like section 125 cafeteria plans or level-funded plans and be willing to accept feedback from employees, industry experts in Spokane suggest.

Eastern Washington University is moving forward with plans to launch a master’s in dental therapy program, a move that would place the university among a small handful of institutions nationwide offering the credential and expand access to oral health care in rural Washington, says Dawn Lewis-Kinnunen, dean of EWU’s College of Health Science and Public Health.

This year, the Spokane Journal of Business celebrates 40 years in this community. As the Journal celebrates 40 years chronicling Spokane’s growth, Providence Sacred Heart Medical Center approaches its own milestone — 140 years of caring for this community.

Spokane Eye Clinic has been acquired by PRISM Vision Group, a New Providence, New Jersey-based general ophthalmology and retina practice management services provider.

Many U.S. businesses are bracing for the sharpest rise in health care costs in more than a decade, with employer coverage costs expected to jump nearly 10%, says Melissa Koontz, senior vice president, employee benefits at the Spokane office of Alliant Insurance Services Inc.

Glyciome LLC, a biotech startup developing microbiome-based genital health products, has moved a major portion of its federally funded clinical trials away from Harvard Medical School and into the Inland Northwest.